Corporate Accountability: Bombay High Court Denies Mahindra’s Challenge to MSMED Arbitral Award

In a decision emphasizing the importance of evidence in commercial litigation, the Bombay High Court has dismissed an appeal by Mahindra Defence Systems Ltd. against a smaller proprietorship, Ranjana Industries. The case, which centered on unpaid dues under the Micro, Small and Medium Enterprises Development (MSMED) Act, 2006, signals a stern warning to large corporations to ensure their litigation policies are anchored in merit rather than obstruction.

The Backdrop: A Supply Chain Breakdown

The dispute arose from three 2017 purchase orders for "QTTM Assembly Section" components. Ranjana Industries, a micro-enterprise, fulfilled the supply, yet claimed that over Rs. 16 lakh remained unpaid. Mahindra, conversely, alleged that the goods were defective and late, leading to a counter-claim of over Rs. 61 lakh for business losses and liquidated damages—citing damages purportedly paid to the Government of India.

However, the Facilitation Council—the statutory body for settling MSMED disputes—found no evidence that Mahindra had actually incurred these losses or that the goods had been returned as claimed. The High Court, presided over by Justice Somasekhar Sundaresan, echoed this assessment in the current appeal.

Key Arguments: Evidence Over Allegation

Mahindra argued that their Quality Assurance team had flagged issues and that the 15-day window for filing objections under the MSMED Act was merely "directory." Ranjana Industries, representing themselves in court, held their ground: there was no contemporaneous correspondence documenting the physical return of goods, and the Sales Tax authorities had pursued them for the VAT that Mahindra had claimed as input credit while simultaneously denying the receipt of the goods.

Justice Sundaresan noted that "the Learned Arbitral Tribunal, which is the master of evidence and the arbiter of the quality and quantity of evidence, has examined these documents and commented on them."

Key Observations from the Court

The judgment highlights a critical failure in the appellant's case: the transition from "observations" to formal "objections" and the total lack of proof regarding the return of the disputed tubes.

• On the burden of proof: "The Learned Arbitral Tribunal has noticed that Mahindra appears to have approached the matter with the criminal standard of proof of requiring Ranjana to prove its claim beyond reasonable doubt... However, by applying the civil standard of preponderance of probability, Ranjana’s version inspired confidence."
• On evidence of return: "The Learned Arbitral Tribunal has noted that there is no proof of dispatch and delivery of the products back to Ranjana."
• On the MSMED deadline: "The definition of the term [appointed day] has firm and specific consequences and it cannot be lightly contended that the deadline is directory and mandatory."
• On the need for introspection: "Large corporates... must set an example by adopting a reasonable litigation policy, in much the same way the private sector expects the State and its agencies not to appeal every adverse decision."

The Verdict: A Lesson in Corporate Responsibility

The Court upheld the award, mandating that Mahindra pay the outstanding sum plus accrued interest under the MSMED Act. Furthermore, the court imposed costs of Rs. 1.5 lakh on the corporate giant to be paid to the respondent.

The decision serves as a significant precedent for micro-enterprises. It clarifies that when a buyer enjoys the benefits of the MSMED Act, they cannot simultaneously disregard its strict timelines and evidentiary standards. More broadly, Justice Sundaresan’s "End-Note" acts as a stinging critique of modern corporate litigation tactics, reminding major players that the legal system is not a sandbox for frustrating smaller, economically weaker parties while hiding behind the complexity of legal hierarchies.

Future litigants should take note: unsubstantiated counter-claims lacking primary evidence, especially regarding the return or testing of goods, are unlikely to find favor in an appellate forum under the Arbitration and Conciliation Act.